Searchable abstracts of presentations at key conferences on calcified tissues

ba0006oc11 | (1) | ICCBH2017

The effect of whole body vibration training on bone and muscle function in children with osteogenesis imperfecta and limited mobility: a randomized controlled pilot trial

Hogler Wolfgang , Bishop Nick , Arundel Paul , Scott Janis , Mughal Zulf , Padidela Raja , Nightingale Peter , Shaw Nick , Crabtree Nicola

Objectives: Osteogenesis imperfecta (OI) is a bone fragility disorder associated with reduced muscle size, dynamic muscle function and mobility. This paired randomised controlled pilot study assessed the effect of whole body vibration (WBV) training on bone density and geometry, muscle size and function, mobility, and balance in children with OI.Methods: Twenty-four children (5–16 years) with OI types 1,4 and limited mobility (defined as a Childhood...

ba0006p169 | (1) | ICCBH2017

Orthopaedic management of leg length discrepancy in Proteus syndrome: a case series

Crenshaw Molly , Goerlich Cara , Ivey Lauren , Sapp Julie , Keppler-Noreuil Kim , Scott Allison , Biesecker Leslie , Tosi Laura

Background: Proteus syndrome (PS) is a rare mosaic disorder comprising asymmetric bony and soft tissue overgrowth leading to significant morbidity. Placement of guided growth hardware with subsequent epiphyseal arrest improves leg length and angular deformities in pediatric patients without PS.Presenting problem: The purpose of this study was to review the surgical approach and present outcomes, complications, and recommendations in eight patients with P...

ba0007p14 | (1) | ICCBH2019

Bone health in children with congenital heart disease

Erlandson Marta , Baril Chantelle , Runalls Shonnah , Lahti Dana , Wright Kristi , Pockett Chrissa , Bradley Tim , Kakadekar Ashok , Pharis Scott , Tomczak Corey

Objectives: Children with congenital heart disease (CHD) have been found to have markedly low levels of physical activity (PA) compared to typically developing peers. It is well known that PA during the growing years has a beneficial effect on bone health with the most active children laying down more bone than their less active peers. If children with CHD are avoiding PA, current and future bone health may be compromised; however, very little is known of the bone health of ch...

ba0007p162 | (1) | ICCBH2019

Bone monitoring and morbidity in adults with duchenne muscular dystrophy: Challenges in implementation of standards of care

Harris Anne-Marie , Di Marco Marina , Raeside David , Davidson Scott , Gallacher Stephen , Farrugia Maria , Wong Sze Choong

Background: Osteoporosis is common in subjects with Duchenne muscular dystrophy (DMD). Studies in paediatric DMD identified a high frequency of fragility fractures but there are no studies in the adult population. Recent updated international standards of care (2018) for children and adults with DMD recommend the following for bone monitoring:- Lateral thoracolumbar spine x-rays to screen for vertebral fracture (1–2 yearly if on glucocorticoid; 2&#1...

ba0002oc1 | Epidemiology | ICCBH2013

The Amalgamated Paediatric Bone Density Study (The ALPHABET Study): the collation and generation of UK based reference data for paediatric bone densitometry

Crabtree Nicola , Machin Mike , Bebbington Natalie , Adams Judith , Ahmed Faisal , Arundel Paul , Bishop Nicholas , Fewtrell Mary , Hogler Wolgang , Mughal M Zulf , Rhodes Laura , Shaw Nicholas , Ward Kate

Understanding normal patterns of bone growth is important for optimising bone health in children and reducing osteoporotic fractures in later life. Recently published guidelines for bone assessment in children state that to predict fractures a technique should identify children at risk of clinically significant fractures and that dual-energy absorptiometry (DXA) is the preferred method of assessment. Despite these guidelines there is still inconsistency and lack of consensus r...

ba0003pp90 | Bone development/growth and fracture repair | ECTS2014

A randomized, double-blind, placebo-controlled, ascending, single-dose study of a human monoclonal anti-FGF23 antibody (KRN23) in X-linked hypophosphatemia

Carpenter Thomas , Imel Erik , Ruppe Mary , Weber Thomas , Klausner Mark , Wooddell Margaret , Kawakami Tetsuyoshi , Ito Takahiro , Zhang Xiaoping , Humphrey Jeffrey , Insogna Karl , Peacock Munro

Purpose: In X-linked hypophosphatemia (XLH), elevated serum FGF23 causes low serum phosphorus (Pi) and inappropriately normal 1,25-dihydroxyvitamin D (1,25(OH)2D) levels. We report safety, tolerability and biochemistry markers following single ascending dose administration of KRN23 in adults with XLH.Methods: 38 XLH subjects with baseline FGF23≥30 pg/ml were randomized to receive single doses of KRN23 (K) or placebo (P) either (0.003&#15...

ba0003pp91 | Bone development/growth and fracture repair | ECTS2014

Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) after ascending single-dose administration in patients with X-linked hypophosphatemia

Zhang Xiaoping , Carpenter Thomas , Imel Erik , Ruppe Mary , Weber Thomas , Klausner Mark , Kawakami Tetsuyoshi , Ito Takahiro , Humphrey Jeffrey , Insogna Karl , Peacock Munro

Purpose: In X-linked hypophosphatemia (XLH), elevated serum FGF23 causes low serum phosphorus (Pi) and inappropriately normal 125-dihydroxyvitamin D (125(OH)2D) levels. We report PK and PD of KRN23 following single ascending dose administration in adults with XLH.Methods: 38 XLH patients with baseline FGF23≥30 pg/ml were randomized to receive a single dose of KRN23 (K) or placebo (P) either i.v. (0.003–0.3 mg/kg) or s.c. (0.1–1...

ba0007oc16 | (1) | ICCBH2019

A natural history study of generalized arterial calcification of infancy (GACI) and autosomal recessive hypophosphatemic rickets (ARHR2) due to ENPP1 or ABCC6 deficiency: interim analysis

Nitschke Yvonne , Kintzinger Kristina , Hackbarth Mary , Botschen Ulrike , Wang Sisi , Gafni Rachel I , Mueller Kerstin , Ahmed Ruhi , Yuen Eric , Gahl William A , Ferreira Carlos R , Rutsch Frank

Introduction: ENPP1 Deficiency manifests as GACI type 1 in infants, a disorder characterized by extensive arterial calcifications and stenoses, often fatal in utero or in early infancy. Beyond six months, the mortality rate significantly decreases among survivors, who may later develop ARHR2, characterized clinically by short stature, bone deformities and pain. ABCC6 Deficiency also manifests as GACI type 2 in infants and is clinically indistinguishable from GACI type 1. Anima...